Linked Life Data

6879067

Source:http://linkedlifedata.com/resource/pubmed/id/6879067

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1983-9-23
pubmed:abstractText
The article reports on the clinical use of sodium and meglumine ioxaglate/Hexabrix, an angiographic contrast medium of low osmolarity. Due to this low osmolarity, favourable experiences were collected in 287 angiographic examinations. Special attention was paid to the question to what extent the contrast medium was responsible for pain, and it was found that Hexabrix definitely causes less pain than the tri-iodated conventional contrast media. During the examination no pain was registered which would have been indicated verbally or by means of movements as involuntary reactions to pain. In arteriography Hexabrix is definitely superior to the conventional contrast media.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0300-8592
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
191-3
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
[Ioxaglic acid, a contrast medium with low osmolarity in clinical use].
pubmed:publicationType
Journal Article, English Abstract